Search

Your search keyword '"Hydrophobic and Hydrophilic Interactions drug effects"' showing total 425 results

Search Constraints

Start Over You searched for: Descriptor "Hydrophobic and Hydrophilic Interactions drug effects" Remove constraint Descriptor: "Hydrophobic and Hydrophilic Interactions drug effects"
425 results on '"Hydrophobic and Hydrophilic Interactions drug effects"'

Search Results

1. Influence of Simvastatin and Pravastatin on the Biophysical Properties of Model Lipid Bilayers and Plasma Membranes of Live Cells.

2. Identification of a small molecule splicing inhibitor targeting UHM domains.

3. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.

4. Partition of antimicrobial D-L-α-cyclic peptides into bacterial model membranes.

5. Heparin Enriched-WPI Coating on Ti6Al4V Increases Hydrophilicity and Improves Proliferation and Differentiation of Human Bone Marrow Stromal Cells.

6. GM3 Ganglioside Linked to Neurofibrillary Pathology in a Transgenic Rat Model for Tauopathy.

7. Electrostatic Forces Mediate the Specificity of RHO GTPase-GDI Interactions.

8. Simple ultrasonic-assisted approach to prepare polysaccharide-based aerogel for cell research and histocompatibility study.

9. Development of polymer-based nanoparticles for zileuton delivery to the lung: PMeOx and PMeOzi surface chemistry reduces interactions with mucins.

10. Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies.

11. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia.

12. Multivalent electrostatic pi-cation interaction between synaptophysin and synapsin is responsible for the coacervation.

13. Structural Water Stabilizes Protein Motifs in Liquid Protein Phase: The Folding Mechanism of Short β-Sheets Coupled to Phase Transition.

14. Hydrophobic and polar interactions of FDA-approved small molecule protein kinase inhibitors with their target enzymes.

15. Tarkhineh as a new microencapsulation matrix improves the quality and sensory characteristics of probiotic Lactococcus lactis KUMS-T18 enriched potato chips.

16. Paclitaxel-Loaded Magnetic Nanoparticles Based on Biotinylated N -Palmitoyl Chitosan: Synthesis, Characterization and Preliminary In Vitro Studies.

17. Investigation on the effect of three isoflavones on the fibrillation of hen egg-white lysozyme.

18. Hydroxy citric acid cross-linked chitosan/guar gum/poly(vinyl alcohol) active films for food packaging applications.

19. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.

20. Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy.

21. Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody-Drug Conjugates.

22. Molecular-Gated Drug Delivery Systems Using Light-Triggered Hydrophobic-to-Hydrophilic Switches.

23. Selected Thoughts on Hydrophobicity in Drug Design.

24. Graphene oxide enhanced ionic liquid plasticisation of chitosan/alginate bionanocomposites.

25. βB2 W151R mutant is prone to degradation, aggregation and exposes the hydrophobic side chains in the fourth Greek Key motif.

26. Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease.

27. Design, synthesis and bioevaluation of inhibitors targeting HSP90-CDC37 protein-protein interaction based on a hydrophobic core.

28. Design of Functional Nanoparticles for Intractable Disease Therapy.

29. In Silico Drug-designing Studies on Sulforaphane Analogues: Pharmacophore Mapping, Molecular Docking and QSAR Modeling.

30. Excretory overexpression of hydrophobins as multifunctional biosurfactants in E. coli.

31. Poly-3-hydroxybutyrate/chitosan composite films and nonwoven mats.

32. Preparation and application of a polymer with pH/temperature-responsive targeting.

33. Antioxidant and antibacterial activities, interfacial and emulsifying properties of the apo and holo forms of purified camel and bovine α-lactalbumin.

34. Fabrication of soy protein isolate/cellulose nanocrystal composite nanoparticles for curcumin delivery.

35. Probing the effect of aroma compounds on the hydrodynamic properties of mucin glycoproteins.

36. Effect of plasticizer and surfactant on the properties of poly(vinyl alcohol)/chitosan films.

37. Tissue-sealing and anti-adhesion properties of an in situ hydrogel of hydrophobically-modified Alaska pollock-derived gelatin.

38. Physicochemical and biological characteristics of chitosan/κ-carrageenan thin layer-by-layer films for surface modification of nitinol.

39. Inverse liquid-solid chromatography to evaluate drug interactions with organosilane-modified polydimethylsiloxane for use in body-on-a-chip systems.

40. Design, synthesis, molecular docking and in vitro evaluation of benzothiazole derivatives as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

41. Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids.

42. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.

43. Comparison of Drug Release and Adsorption under Supersaturating Conditions for Ordered Mesoporous Silica with Indomethacin or Indomethacin Methyl Ester.

44. Membrane pore-formation correlates with the hydrophilic angle of histidine-rich amphipathic peptides with multiple biological activities.

45. Cyclodextrin binding constants as a function of pH for compounds with multiple pK a values.

46. Comparison of Chemotherapeutic Activities of Rhodamine-Based GUMBOS and NanoGUMBOS.

47. Fast chemical force microscopy demonstrates that glycopeptidolipids define nanodomains of varying hydrophobicity on mycobacteria.

48. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection.

49. Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies.

50. Insight into the binding behavior of ceritinib on human α-1 acid glycoprotein: Multi-spectroscopic and molecular modeling approaches.

Catalog

Books, media, physical & digital resources